Javier L. J.
- Country
- Spain
- Department
- Cardiology
Research Overview
- Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Single Versus Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly or High Bleeding Risk Patients Post-PCI with Drug-Coated Balloons
Data & Insights
Has run more than one trial at 7 of 358 partner sites.
Specializations
Cardiovascular Disease Management
This investigator specializes in treating patients with atherosclerotic cardiovascular disease (ASCVD), focusing on preventive approaches for major cardiovascular events such as cardiovascular death, heart attacks, and strokes.
- Risk Reduction Strategies
- Lipid Management
- Preventive Cardiology
Their research interests include innovative therapeutic approaches for patients with elevated LDL cholesterol levels.
Specialized Coronary Conditions
The investigator has developed expertise in treating Spontaneous Coronary Artery Dissection (SCAD), a rare but significant cardiovascular condition affecting coronary arteries.
- Medical Therapy Optimization
- Beta-Blocker Treatment
- Antiplatelet Therapy
Their work encompasses evaluation of various therapeutic combinations for optimal patient outcomes in SCAD management.
Therapeutic Approaches
The investigator focuses on developing comprehensive treatment strategies incorporating both pharmaceutical interventions and preventive therapies for cardiovascular conditions.
- Cardiovascular Risk Assessment
- Medication Efficacy Evaluation
- Treatment Protocol Development
Their expertise extends to evaluating therapeutic efficacy in complex cardiovascular conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.